Summer 2020 Helix Magazine

Meeting the COVID Challenge

RFU expanded its Clinical Immunology Lab in response to the national call for increased testing capacity for SARS-CoV-2, the virus that causes COVID-19.

Flexibility, Ingenuity, Perseverance

Directors in the Innovation and Research Park reflect on how they and their teams are coping in the time of COVID-19.

NIH Grant Will Test Therapeutic Approach for CLN3 Batten Disease

Michelle Hastings, PhD, was awarded a grant to discover treatments for CLN3 Batten disease, a fatal neurodegenerative disease affecting young children.

Announcing Key Recruitments to the Brain Science Institute

Dr. Eun Jung Hwang and Dr. Sarah Johnson officially join RFU as tenure track assistant professors in CMS’s Department of Foundational Sciences and Humanities.

Fostering Excellence in Biomedical Research

Kelly Wilson, SGPS ’21, a graduate research assistant in the lab of Dr. Johnny He, director of the Center for Cancer Cell Biology, Immunology and Infection, reflects on her experience as an early career investigator.

Collaborating Across Systems

Strong collaboration across universities, health systems and the federal government is speeding the national Expanded Access Program to collect and provide convalescent plasma to seriously ill COVID-19 patients.

Investing in Innovation

Helix 51 incubator company Inspirotec announced in March that its commercially available air sampling device (AirAnswers™) has the capability to detect viruses in the air, including COVID-19.